EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models
Clinical Trials: Failures and Challenges on the Path to Treating Alzheimer’s
Alzheimers disease AD is a neurodegenerative disorder with symptoms of memory loss and cognitive disability Typically it begins with mild symptoms that progress to become more severe AD is the th leading cause of death in the United States among people or older In million Americans suffered from AD and this is expected to rise to million by
Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus
Paracelsus in the th century established the principle of toxicology that the dose of a medicinal defines the difference between a remedy and a toxic effect
Innovative Solutions: Cell and Gene Therapy's Impact on Pharma
Cell therapy involves the use of living cells to treat medical conditions These cells can be sourced from a patient or a donor and are often manipulated or engineered to enhance their therapeutic effects
Chromatography: Principles, Techniques, Applications, and Future Developments
Chromatography is one of the most influential analytical techniques developed in modern science First introduced by Mikhail Tswett in the early twentieth century the technique has evolved into an indispensable tool for separating identifying quantifying and purifying chemical and biological substances
Cybersecurity in Pharma: The Threat No One Budgeted For
There is a particular kind of risk that organisations are bad at pricing the one that has never happened to them Pharmaceutical companies have spent a generation building sophisticated defences against the risks they know intimatelycontamination adulteration deviation recall Quality systems are mature inspectionready and deeply funded Cyber risk has never enjoyed that status It sat in the IT budge...
-
Techno Trends
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC
-
Projects
Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion
Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Clinical Trials: Failures and Challenges on the Path to Treating Alzheimer’s
Ronny Priefer
Jinwoo Lee
This year marks the 30th anniversary of the approval of tacrine, the first drug targeting Alzheimer’s disease. Although not a curative agent, it provided some assistance to those afflicted with...
-
2
Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus
William M. Pardridge
The development of biologics for the treatment of neural disorders has been slow, because these large molecule drugs do not cross the blood-brain barrier (BBB). Solutions to the BBB drug delivery prob...
-
3
Innovative Solutions: Cell and Gene Therapy's Impact on Pharma
Kate Williamson
In recent years, the field of medicine has witnessed revolutionary advancements in cell and gene therapy, ushering in a new era of treatment possibilities. These innovative solutions have the potentia...
-
4
Chromatography: Principles, Techniques, Applications, and Future Developments
Venkata Reddy Pothireddy
Chromatography is a powerful analytical and purification technique widely used in pharmaceutical, biotechnology, clinical, environmental, and food industries. It enables effective separation, identifi...
-
5
Cybersecurity in Pharma: The Threat No One Budgeted For
Lakshmi
Pharma spent a generation hardening itself against contamination and recall—while cyber risk stayed a forgotten IT line item. That framing has collapsed. Today's attackers don't just ste...
press releases Read more...
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Amneal Pharmaceuticals Inc Amneal or the Company NASDAQ AMRX today announced that the US Food and Drug Administration FDA has approved its lanreotide injection mg mL in a sterile
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA
Acelot Announces Initiation of Dosing in Phase Ia Clinical Trial of ACE-2223, a First-in-Class Oral Small Molecule Targeting Aggregated TDP-43 in Amyotrophic Lateral Sclerosis (ALS)
Acelot a biotechnology company developing small molecule therapies for challenging targets in diseases with high unmet need today announced the initiation of the Phase Ia clinical trial of ACE
Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution
Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWS Read more...
BioCytics and Eremid collaborate on single-cell sequencing study for cancer cell therapy
BioCytics Inc has engaged Eremid Genomic Services to sequence an autologous immune cell fraction being developed for its immunebased cancer cell therapy programme
MAbxience and Sandoz collaborate to advance global access to emicizumab biosimilar
MAbxience majorityowned by Fresenius SE Co KGaA with partial ownership from Insud Pharma has entered into a licensing development manufacturing and commercialisation agreement with Sandoz for an emicizumab
Orbis Medicines enters multi-target drug discovery partnership with Novo Nordisk
Orbis Medicines has entered a strategic collaboration and licence agreement with Novo Nordisk to discover and develop nextgeneration oral macrocycle medicines for cardiometabolic diseases
Everest Clinical Research expands global biometrics capabilities with Firma DS acquisition
Everest Clinical Research has acquired the Biometrics and Data Services business unit of Firma Clinical Research expanding its global biometrics expertise and clinical data science capabilities
Novo Nordisk and Anthropic collaborate to advance AI-led drug discovery
Novo Nordisk and Anthropic have announced a collaboration to accelerate drug discovery and development using artificial intelligence AI while also expanding AIsupported software development at Novo
Twist Bioscience joins Lilly TuneLab to support antibody drug discover
Twist Bioscience has entered into an agreement with Lilly TuneLab an artificial intelligence and machine learning AIML drug discovery platform developed by Eli Lilly and Company





